Products for Research Use Only
RegisterLogin

Ribociclib succinate

CAT: 0013-GTR19174355-07Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19174355-07Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ribociclib succinate (LEE011 succinate) is a potent and selective inhibitor of CDK4 and CDK6, with IC50 values of 10 nM and 39 nM, respectively, while showing minimal activity against CDK1. It is widely used in cancer research, particularly for studying cell cycle arrest in breast cancer models, both in vitro and in vivo.
CAS Number
1374639-75-4
Product Name Alternative
Inhibitor, LEE 011, LEE011 Succinate, LEE011 succinate, LEE-011 Succinate, LEE 011 Succinate, LEE011, LEE-011, inhibit, CDK6, CDK4, CDK, Cyclin dependent kinase, Ribociclib, Ribociclib succinate, Ribociclib Succinate
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
99.57% (May vary between batches)
Solubility
DMSO:9 mg/mL (16.29 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:0.5 mg/mL (0.9 mM)
Smiles
OC (=O) CCC (O) =O.CN (C) C (=O) c1cc2cnc (Nc3ccc (cn3) N3CCNCC3) nc2n1C1CCCC1
Molecular Formula
C27H36N8O5
Molecular Weight
552.63
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Ribociclib Succinate

Ribociclib Succinate is the succinate salt form of ribociclib, an orally available inhibitor of the cyclin-dependent kinases (CDKs) 4 and 6, with antineoplastic activity. Upon oral administration, ribociclib specifically targets, binds to and inhibits CDK4 and CDK6. This inhibits the cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, which inhibits phosphorylation of the retinoblastoma (Rb) protein. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle dysregulation.

CAS Number1374639-75-4
PubChem CID57334219
IUPAC Namebutanedioic acid;7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide
Molecular FormulaC27H36N8O5
Molecular Weight552.6
Topological Polar Surface Area166
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count11
Rotatable Bond Count8
Heavy Atom Count40
Formal Charge0
Complexity728
SMILES
CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5.C(CC(=O)O)C(=O)O
InChI
InChI=1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8)
InChIKey
NHANOMFABJQAAH-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Ribociclib Succinate
CAS: 1374639-75-4
CID: 57334219
Formula: C27H36N8O5
MW: 552.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight552.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count11
Rotatable Bond Count8
Exact Mass552.28086628
Monoisotopic Mass552.28086628
Topological Polar Surface Area166 Ų
Heavy Atom Count40
Formal Charge0
Complexity728
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19172084-01Ribociclib
GTR19203656-01Ribociclib hydrochloride
GTR19213111-01Succinate/succinate receptor antagonist 1
GTR19175725-01Tafenoquine Succinate
GTR19202654-01Monooctyl succinate
GTR19244785-01Diammonium succinate
GTR19217901-01Tocopherol succinate
GTR19211607-01Batefenterol Succinate
GTR19193930Lavoltidine succinate
GTR19191748-01Epitinib succinate

Alternative Products

CatalogName
M22128-01Ribociclib succinate
ZEC63979-01Ribociclib succinate hydrate
HY-15777BR-01Ribociclib succinate (Standard)

Popular Products